OLDSMAR, Fla., Sept. 24 /PRNewswire-FirstCall/ -- Cryo-Cell International, Inc., one of the world's largest private cord blood banks and a developer of innovative stem cell solutions, announced today that the Company has entered into agreements to launch its proprietary new service, C'elle(TM), to seven countries in Europe, Latin America and Southeast Asia. Cryo-Cell's innovative service, introduced in November, 2007, is the first available service that enables women to collect and cryopreserve highly prolific stem cells harvested from menstrual flow. C'elle was developed by researchers at Cryo-Cell following the Company's discovery of unique and highly prolific stem cells in menstrual fluid.
Cryo-Cell has formalized agreements with C'elle distribution partners in the United Kingdom, Ireland, Italy, Greece, Venezuela and Panama. Cryo-Cell's technology license partner, LifeCell Private Ltd., previously announced plans to introduce the C'elle service in India. C'elle has the potential to benefit millions of women worldwide, since stem cells found in menstrual blood may potentially be utilized in a broad range of future regenerative therapies to possibly treat a number of debilitating conditions such as heart disease, stroke and diabetes. C'elle stem cells may also have potential to be used in cosmeceutical applications such as anti-aging and wound-healing.
'We are very excited to partner with Cryo-Cell International to distribute C'elle throughout Ireland and the UK,' said Michael Doherty, Managing Director, Medicare Health & Living Ltd. 'Cryo-Cell International is renowned for its high standards and excellence. We believe that C'elle has the potential to revolutionize women's health globally. This is truly a great opportunity to bring an exclusive and innovative product to the women of Ireland and the UK enabling them to store their very own portfolio of stem cells.'
Cryo-Cell continues to explore new global commercial and scientific partnerships and recognizes that the regenerative potential of C'elle may one day help to advance women's healthcare around the world. With the international launch of C'elle, Cryo-Cell's global partners will have a unique opportunity to expand their business models with a proprietary and highly differentiated service.